US Stock MarketDetailed Quotes

Bluejay Diagnostics (BJDX)

Watchlist
  • 4.590
  • -0.150-3.16%
Trading Jun 12 12:49 ET
4.75MMarket Cap-1.23P/E (TTM)

About Bluejay Diagnostics Company

Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.

Company Profile

SymbolBJDX
Company NameBluejay Diagnostics
Listing DateNov 10, 2021
Issue Price10.00
ISINUS0956336087
Founded2015
CEOMr. Indranil Dey
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address360 Massachusetts Avenue,Suite 203
CityActon
ProvinceMassachusetts
CountryUnited States of America
Zip Code01720
Phone1-978-631-4884

Company Executives

  • Name
  • Position
  • Salary
  • Indranil Dey
  • President, Chief Executive Officer and Director
  • 473.56K
  • Donald R. Chase
  • Chairman of the Board
  • 111.77K
  • Svetlana Dey
  • Director
  • 62.50K
  • Fred S. Zeidman
  • Independent Director
  • 93.06K
  • Douglas C. Wurth
  • Independent Director
  • 110.36K
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More